Global ICAD (Intracranial Atherosclerotic Disease) Pathology Revenue Is Nearly 134 M USD In 2017
Friday, 02 Nov, 2018
In the last several years, global market of ICAD (Intracranial Atherosclerotic Disease) Pathology developed rapidly, with an average growth rate of 8.70%. In 2017, global revenue of ICAD (Intracranial Atherosclerotic Disease) Pathology is nearly 134 M USD; the actual Sales is about 56 K units.

The classification of ICAD (Intracranial Atherosclerotic Disease) Pathology includes Stent and PTA?Balloon, and the proportion of Stent in 2017 is about 80.15%.

ICAD (Intracranial Atherosclerotic Disease) Pathology is widely used in Hospital, Clinic and other field. The most proportion of ICAD (Intracranial Atherosclerotic Disease) Pathology is Hospital, and the consumption proportion in 2017 is about 63%.

North America is the largest Sales place, with a Sales market share nearly 26% in 2017. Following North America, Europe is the second largest Sales place with the Sales market share of 20%.

Market competition is intense. Stryker, Balt, TERUMO, MicroPort, Acandis, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.